跳至主要内容
临床试验/NCT00448188
NCT00448188已完成不适用

Thrombocytes and International Normalized Ratio Are no Predictors for Bleeding in Application of Central Veneous Catheters

Heidelberg University2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2005年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
2
主要终点
Bleeding within 24 hours after cvc application

研究概览

简要总结

Since many of the patients in an intensive care unit suffer from disorders of hemostasis, bleeding is a main concern applying central venous catheters. Even if there are some data indicating elevated international normalized ratio may not increase the risk of bleeding no clear cut-off has been defined so far. An INR > 1.5 is generally considered to increase the risk of bleeding. Furthermore, many authors consider platelets below 50 x 109 /l as a contra-indication to CVC cannulation, since there are some data this may increase the risk of bleeding. Therefore platelet transfusion before venous puncture is suggested. In our clinical experience INR > 1.5 and platelets < 50 x 109 /l do not correlate with increased risk of bleeding. The aim of this study is to demonstrate, that coagulopathy, defined by INR and platelet count, is not decisive for bleeding.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients acquiring a central venous catheter

排除标准

  • Patients pre or post surgery
  • Patients with bleeding due to other reason

结局指标

主要结局

Bleeding within 24 hours after cvc application

other complications within the first 24 hours

次要结局

  • mortality
  • long-term complications

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Bleeding Risk in CVCs | 临床试验